Introduction
obesity, Type 2 diabetes, T2D
OBESITY, TYPE 2 DIABETES
Type 2 diabetes (T2D) epidemic is a major health concern, and obesity is contributing to the increase in T2D prevalence (Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a new emerging drug class in treatment of T2D that act on several targets including the pancreatic β-cell, liver, kidney, brain, and CV system (